Literature DB >> 1003502

Immunologic parameters of ultraviolet carcinogenesis.

M L Kripke, M S Fisher.   

Abstract

Skin tumors induced in mice by UV light are usually immunologically rejected by normal syngeneic recipents. We evaluated the immune status of primary hosts against these highly antigenic tumors immediately after surgical removal of the primary tumor. All primary hosts were susceptible to challenge with their autochthonous tumors, though most of these were rejected by untreated control mice. Primary hosts were also susceptible to challenge with isografts of antigenically dissimilar UV-induced neoplasms. The susceptibility of the primary hosts to tumor challenge was probably induced by chronic exposure to UV light, since UV-irradiated non-tumor-bearing mice were also susceptible to challenge with these tumors. Although UV-treated mice were unalbe to reject these syngeneic tumors, they could reject skin and tumor allografts. Further, UV irradiation did not interfere with the second-set rejection of syngeneic UV-induced tumors in mice that were specifically immunized before UV treatment.

Entities:  

Mesh:

Year:  1976        PMID: 1003502     DOI: 10.1093/jnci/57.1.211

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  49 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

2.  Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid.

Authors:  R B Setlow; A D Woodhead; E Grist
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Impairment of antigen-presenting cell function by ultraviolet radiation.

Authors:  M I Greene; M S Sy; M Kripke; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Fluorescent lighting enhances chemically induced papilloma formation and increases susceptibility to tumor challenge in mice.

Authors:  A Wiskemann; E Sturm; N W Klehr
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer.

Authors:  Amy A Irving; Lori A Plum; William J Blaser; Madeline R Ford; Chao Weng; Linda Clipson; Hector F DeLuca; William F Dove
Journal:  J Nutr       Date:  2014-12-24       Impact factor: 4.798

6.  Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma.

Authors:  Dana E Rollison; Anna R Giuliano; Jane L Messina; Neil A Fenske; Basil S Cherpelis; Vernon K Sondak; Richard G Roetzheim; Michelle R Iannacone; Kristina M Michael; Tarik Gheit; Tim Waterboer; Massimo Tommasino; Michael Pawlita
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-20       Impact factor: 4.254

7.  Sun exposure, sexual behavior and uterine cervical human papilloma virus.

Authors:  William J M Hrushesky; Robert B Sothern; Wop J Rietveld; Jovelyn Du-Quiton; Mathilde E Boon
Journal:  Int J Biometeorol       Date:  2005-10-06       Impact factor: 3.787

8.  Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse.

Authors:  T Kitajima; M Iwashiro; K Kuribayashi; S Imamura
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

9.  CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.

Authors:  Marleen M Welsh; Katie M Applebaum; Steven K Spencer; Ann E Perry; Margaret R Karagas; Heather H Nelson
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

10.  UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion.

Authors:  K D Cooper; L Oberhelman; T A Hamilton; O Baadsgaard; M Terhune; G LeVee; T Anderson; H Koren
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.